Autek China Inc. (SHE:300595)

Market Cap	9.19B -36.3%
Revenue (ttm)	1.82B +0.1%
Net Income	440.40M -10.4%
EPS	0.49 -10.4%
Shares Out	895.29M
PE Ratio	20.80
Forward PE	18.12
Dividend	0.13 (1.25%)
Ex-Dividend Date	Oct 20, 2026

Volume	8,979,481
Open	9.89
Previous Close	10.44
Day's Range	9.89 - 10.57
52-Week Range	9.73 - 17.37
Beta	0.62
Analysts	Hold
Price Target	13.01 (+26.8%)
Earnings Date	Oct 27, 2026

About Autek China

Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic and optometry medical devices. Autek China Inc. was incorporated in 2000 and is based in Hefei, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 3,752
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300595

Financial Performance

In 2025, Autek China's revenue was 1.86 billion, an increase of 2.62% compared to the previous year's 1.81 billion. Earnings were 479.52 million, a decrease of -16.20%.

Analyst Summary

According to 4 analysts, the average rating for 300595 stock is "Hold." The 12-month stock price target is ¥13.01, which is an increase of 26.80% from the latest price.

Price Target

¥13.01

(26.80% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 27, 2026

Data Sources Report a data error